WASHINGTON — Pfizer Inc., the world's largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription-drug promotions. Announcing the settlement Wednesday, the ...
U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera , capping a fierce biotech bidding ...
Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
MiBolsilloColombia on MSN
Pfizer buys Metsera in $10 billion deal to join booming weight loss drug race
Pfizer has acquired Metsera for $10 billion, entering the fast-growing weight loss drug market and intensifying competition ...
President Donald Trump announced on Tuesday a drug pricing deal with Pfizer that will see the pharmaceutical giant lower the cost of its medications for Americans. Trump made the announcement from the ...
Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pfizer has earned a nod from the U.S. regulator for another of its products in the indication. On Friday, the FDA signed off ...
Pfizer’s multi-year effort to stabilize its U.S. penicillin supply has hit an unexpected hitch after particulate concerns prompted a recall of the company’s long-acting injectable form of the ...
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...
This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback